[Answered] The principal drawback of 3DES is that the algorithm is relatively sluggish in software. ...

This topic contains a solution. Click here to go to the answer

Author Question: The principal drawback of 3DES is that the algorithm is relatively sluggish in software. ... (Read 69 times)

NguyenJ

Hero Member
Posts: 516

on: Jul 7, 2018

The principal drawback of 3DES is that the algorithm is relatively sluggish in software.

Indicate whether the statement is true or false.

Question 2

Interviewing requires a great amount of people skill and experience.

Indicate whether the statement is true or false

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

ryrychapman11

Sr. Member
Posts: 334

Reply #1 on: Jul 7, 2018

Answer to Question 1

T

Answer to Question 2

TRUE

NguyenJ

Member
Posts: 516

Reply 2 on: Jul 7, 2018

Excellent

ebonylittles

Member
Posts: 318

Reply 3 on: Yesterday

Wow, this really help

« previous next »

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Normal urine is sterile. It contains fluids, salts, and waste products. It is free of bacteria, viruses, and fungi.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.